Special Issue "Hepatitis B Virus: From Diagnostics to Treatments"
Deadline for manuscript submissions: closed (30 June 2020).
Interests: Viral Hepatitis; Hepatitis B; Hepatitis C; Hepatitis D
Following the recent treatment revolution for Hepatitis C, there is now renewed international interest in Hepatitis B. The World Health Organization has set global elimination targets for Hepatitis B, and there is increased optimism for finding a Hepatitis B cure. In light of this interest, the respected international journal Viruses has decided to release a Special Issue on Hepatitis B, to update readers on the latest developments in this rapidly advancing field.
The Special Issue, titled “Hepatitis B Virus: From Diagnostics to Treatments”, will include a range of invited articles from leaders in the field. Articles will cover basic viral pathogenesis, viral immunology, natural history, epidemiology, and clinical aspects of Hepatitis B virus infection. The Special Issue will provide an overview of the history of Hepatitis B research, with a particular focus on recent advances in diagnostics and treatment.
Fifty years since the discovery of the Australia antigen, it is an exciting time for Hepatitis B virus research. This Special Issue aims to build that momentum, by updating Hepatitis B researchers, attracting new ones, and increasing general awareness of this devastating disease. Only continued international collaboration can achieve the ultimate aims: improving the lives of people with hepatitis B and global elimination of this virus as a public health threat.
Dr. Mark W. Douglas
Dr. Thomas Tu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Hepatitis B virus
- Hepatitis B
- chronic liver disease
- hepatocellular carcinoma
- liver cancer
- chronic hepatitis
- antiviral therapy